|
Frequency and spectrum of CHEK2 variants in a large Brazilian set of germline-tested patients. |
|
|
No Relationships to Disclose |
|
Carolina de Bustamante Fernandes |
Employment - OC Precision Medicinie |
|
Ana Carolina Branco Neves Silva |
No Relationships to Disclose |
|
Fernanda Orpinelli Ramos do Rego |
No Relationships to Disclose |
|
Fernanda Christtanini Koyama |
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Employment - Grupo Oncoclínicas; Rede D'Or São Luiz |
|
|
Honoraria - AstraZeneca; GlaxoSmithKline; Grunenthal; MSD Oncology; Pfizer; Pfizer; United Medical |
Consulting or Advisory Role - AstraZeneca; GlaxoSmithKline; MSD Oncology |
|
Leandro Jonata de Carvalho Oliveira |
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
Ivana Lucia de Oliveira Nascimento |
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
Renata Gondim Meira Velame de Azevedo |
No Relationships to Disclose |
|
João Paulo Gonzaga de Farias |
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Employment - Oncoclínicas |
Stock and Other Ownership Interests - Trialing Health |
Consulting or Advisory Role - Boehringer Ingelheim; Foundation Medicine; Roche |
Speakers' Bureau - Amgen; AstraZeneca; GlaxoSmithKline; Ipsen; Libbs; Lilly; MSD Oncology; Roche; Sanofi; SERVIER |
|
|
|
Employment - Grupo Oncoclinicas |
Stock and Other Ownership Interests - Grupo Oncoclinicas |
Honoraria - Grupo Oncoclinicas |